Polymeric Nanoparticles Containing Combination Antiretroviral Drugs for HIV Type 1 Treatment

Por Shibata, Annemarie, McMullen, Emily, Pham, Alex, Belshan, Michael, Sanford, Bridget, Zhou, You, Goede, Michael, Date, Abjijit A., Destache, Christopher J.
Publicado em 2013

Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism.

Por Liang, H C, Li, H, McKinnon, R A, Duffy, J J, Potter, S S, Puga, A, Nebert, D W
Publicado em 1996

SGLT-2 Inhibitors in Development for Type 2 Diabetes Treatment

Por Bhartia, Mithun, Tahrani, Abd A., Barnett, Anthony H.
Publicado em 2011

Unique Thermodynamic Response of Tipranavir to Human Immunodeficiency Virus Type 1 Protease Drug Resistance Mutations

Por Muzammil, S., Armstrong, A. A., Kang, L. W., Jakalian, A., Bonneau, P. R., Schmelmer, V., Amzel, L. M., Freire, E.
Publicado em 2007

Circulating T cells to infliximab are detectable mainly in treated patients developing anti‐drug antibodies and hypersensitivity reactions

Por Vultaggio, A., Petroni, G., Pratesi, S., Nencini, F., Cammelli, D., Milla, M., Prignano, F., Annese, V., Romagnani, S., Maggi, E., Matucci, A.
Publicado no Clin Exp Immunol (2016)

Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene...

Por Wiley, Luke A., Burnight, Erin R., Drack, Arlene V., Banach, Bailey B., Ochoa, Dalyz, Cranston, Cathryn M., Madumba, Robert A., East, Jade S., Mullins, Robert F., Stone, Edwin M., Tucker, Budd A.
Publicado no Hum Gene Ther (2016)

Altered Strand Transfer Activity of a Multi-drug-resistant Human Immunodeficiency Virus Type 1...

Por Nguyen, Laura A., Daddacha, Waaqo, Rigby, Sean, Bambara, Robert A., Kim, Baek
Publicado em 2011

Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

Por Christopher S. Koivisto, Melodie Parrish, Santosh B. Bonala, Soo Ngoi, Adrian Torres, James Gallagher, Rebekah Sanchez-Hodge, Victor Zeinner, Georges J. Nahhas, Bei Liu, David E. Cohn, Floor J. Backes, Paul J. Goodfellow, Helen M. Chamberlin, Gustavo Leone
Publicado em 2020-10-01

Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus

Por Elisa S. Roesti, Christina N. Boyle, Daniel T. Zeman, Marcos Sande-Melon, Federico Storni, Gustavo Cabral-Miranda, Alexander Knuth, Thomas A. Lutz, Monique Vogel, Martin F. Bachmann
Publicado em 2020-03-01

Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma

Por Plotkin, Scott R., Halpin, Chris, Blakeley, Jaishri O., Slattery, William H., Welling, D. Bradley, Chang, Susan M., Loeffler, Jay S., Harris, Gordon J., Sorensen, A. Gregory, McKenna, Michael J., Barker, Fred G.
Publicado em 2009

Study of the Effect of Polymorphic Markers of the NAT2 Gene on the Risk of Adverse Drug Reactions...

Por A. A. Kachanova, Yu. A. Pimenova, G. N. Shuev, K. A. Akmalova, Zh. A. Sozaeva, N. M. Krasnova, E. A. Grishina, D. A. Sychev
Publicado em 2021-03-01

P-type ATPases in Health and Disease

Por Sigrid A. Langhans, Olga Vagin, Laura Andrea Dada
Publicado no Frontiers Research Topics (2019)

ORLISTAT IN COMBINATION THERAPY OF OBESITY AND TYPE 2 DIABETES

Por A. M. Mkrtumyan, E. V. Biryukova
Publicado em 2017-12-01

Islet Encapsulation: New Developments for the Treatment of Type 1 Diabetes

Por Qi Zhang, Carmen Gonelle-Gispert, Yanjiao Li, Zhen Geng, Zhen Geng, Sandrine Gerber-Lemaire, Yi Wang, Yi Wang, Leo Buhler, Leo Buhler, Leo Buhler
Publicado em 2022-04-01

Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target

Por Galanopoulou, Aristea S., Gorter, Jan A., Cepeda, Carlos
Publicado em 2012

Emerging treatment options for type 2 diabetes

Por Piya, Milan K, Tahrani, Abd A, Barnett, Anthony H
Publicado em 2010

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management

Por Chaudhury, Arun, Duvoor, Chitharanjan, Reddy Dendi, Vijaya Sena, Kraleti, Shashank, Chada, Aditya, Ravilla, Rahul, Marco, Asween, Shekhawat, Nawal Singh, Montales, Maria Theresa, Kuriakose, Kevin, Sasapu, Appalanaidu, Beebe, Alexandria, Patil, Naveen, Musham, Chaitanya K., Lohani, Govinda Prasad, Mirza, Wasique
Publicado no Front Endocrinol (Lausanne) (2017)

Sphingolipids in Obesity, Type 2 Diabetes, and Metabolic Disease

Por Russo, S.B., Ross, J.S., Cowart, L.A.
Publicado em 2013

Effect of the botulinum toxin injections and endoscopic pneumocardiodilation on symptoms severity and treatment outcomes among patients with primary esophageal sphincter achalasia

Por A. Kiosov
Publicado em 2021-10-01

A review of the efficacy and safety of the finished fixed-ratio combination of insulin degludec and liraglutide in the treatment of type 2 diabetes mellitus

Por A. S. Pogorelova
Publicado em 2018-07-01